BackKalaris Therapeutics Overview
Kalaris Therapeutics Inc

Kalaris Therapeutics Target Price

Analysts' 12-month price predictions for KLRS.

Get informed when a big investor buys or sells

+ Follow

Share Price

$4.72

Average Target Price

$18.00281.4% upside

3 analysts in the last 4 months

High: $23 | Low: $14

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-05-14Wedbush$17260.2% upsideOpen
2026-04-16Morgan Stanley$14196.6% upsideOpen
2026-03-09Raymond JamesChris Raymond$23387.3% upsideOpen
2025-12-23Chardan Capital$19302.5% upsideOpen
2025-07-23Piper SandlerBiren Amin$336.4% downsideOpen